Zobrazeno 1 - 10
of 1 699
pro vyhledávání: '"S. Mittra"'
Autor:
Erik S. Mittra, Rebecca K. S. Wong, Celeste Winters, Adam Brown, Shondra Murley, Hagen Kennecke
Publikováno v:
Cancer Medicine, Vol 13, Iss 3, Pp n/a-n/a (2024)
Abstract Radioligand therapy (RLT) is a targeted approach to treating cancer that has been shown to be safe and effective in a variety of disease states, including gastroenteropancreatic neuroendocrine tumors, lymphoma, and most recently, advanced pr
Externí odkaz:
https://doaj.org/article/90718968283449e38ad47eacbe1a3e5c
Autor:
Hatcher, Myron E.
Publikováno v:
Interfaces, 1989 Sep 01. 19(5), 87-89.
Externí odkaz:
https://www.jstor.org/stable/25061279
Autor:
Joshi, Navin Chandra
Publikováno v:
India Quarterly, 1972 Oct 01. 28(4), 402-403.
Externí odkaz:
https://www.jstor.org/stable/45070370
Autor:
Sonya Y. Park, Camila Mosci, Meena Kumar, Mirwais Wardak, Norman Koglin, Santiago Bullich, Andre Mueller, Mathias Berndt, Andrew W. Stephens, Frederick T. Chin, Sanjiv S. Gambhir, Erik S. Mittra
Publikováno v:
EJNMMI Research, Vol 10, Iss 1, Pp 1-12 (2020)
Abstract Purpose (4S)-4-(3-[18F]Fluoropropyl)-l-glutamic acid ([18F]FSPG) measures system xC − transporter activity and shows promise for oncologic imaging. We present data on tumor uptake of this radiopharmaceutical in human subjects with head and
Externí odkaz:
https://doaj.org/article/97f3df152e174153b67cf1d6636b932f
Autor:
Boris G. Naraev, Josh Mailman, Thorvardur R. Halfdanarson, Heloisa P. Soares, Erik S. Mittra, Julie Hallet
Publikováno v:
Expert Review of Anticancer Therapy. 23:601-615
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bd16bc069ae72bd35b067ca474ef8e08
https://doi.org/10.1080/14737140.2023.2207829
https://doi.org/10.1080/14737140.2023.2207829
Autor:
Mirwais Wardak, Ida Sonni, Audrey P. Fan, Ryogo Minamimoto, Mehran Jamali, Negin Hatami, Greg Zaharchuk, Nancy Fischbein, Seema Nagpal, Gordon Li, Norman Koglin, Mathias Berndt, Santiago Bullich, Andrew W. Stephens, Ludger M. Dinkelborg, Ty Abel, H. Charles Manning, Jarrett Rosenberg, Frederick T. Chin, Sanjiv Sam Gambhir, Erik S. Mittra
Publikováno v:
Radiology, vol 303, iss 3
Radiology
Radiology
BACKGROUND: The PET tracer (4S)-4-(3-[(18)F]fluoropropyl)-l-glutamate ((18)F-FSPG) targets the system x(C)(–) cotransporter, which is overexpressed in various tumors. PURPOSE: To assess the role of (18)F-FSPG PET/CT in intracranial malignancies. MA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::479d61e23cb7b4b588b15e67c41ceb39
https://doi.org/10.1148/radiol.203296
https://doi.org/10.1148/radiol.203296
Autor:
Dae Hyuk Moon, Sanjiv S. Gambhir, Erik S. Mittra, Ludger M. Dinkelborg, Christoph A. Schatz, Christina Hultsch, Norman Koglin, Lüder Fels, Claudia Bacher-Stier, Seung Jun Oh, Jin-Sook Ryu, Gyungyub Gong, Jong Won Lee, Sei Hyun Ahn, Chang-Min Choi, Sora Baek
AVI, 161K, Maximum intensity projection of 18FFSPG in a breast cancer patient (Patient 13).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34f84b67d5b41d74f576418fe404d987
https://doi.org/10.1158/1078-0432.22452335.v1
https://doi.org/10.1158/1078-0432.22452335.v1
Autor:
Sanjiv S. Gambhir, May Han, Venkataraman Sriram, Jason Karamchandani, Frank I. Lin, Hua Fan-Minogue, Erik S. Mittra
Supplementary Tables - PDF file 86K, Supplementary Table 1. Overall results of 2nd experiment shown as percent change from baseline by experimental group: Control, Low Dose, and High Dose. Supplementary Table 2. Mitotic activity and Ki-67 labeling in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::412b709cfb42c5d57b6a52df832fffad
https://doi.org/10.1158/1078-0432.22448541.v1
https://doi.org/10.1158/1078-0432.22448541.v1
Autor:
Sanjiv S. Gambhir, May Han, Venkataraman Sriram, Jason Karamchandani, Frank I. Lin, Hua Fan-Minogue, Erik S. Mittra
Supplementary Figures - PDF file 110K, Supplementary Figure 1. Dose titration curves of ficlatuzumab. The numbers in parenthesis are the median survival in days. Supplementary Figure 2. combination therapy of ficlatuzumab and temozolomide studied in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a98790e186d692bf93cdbc2f567dacd9
https://doi.org/10.1158/1078-0432.22448544.v1
https://doi.org/10.1158/1078-0432.22448544.v1
Autor:
Dae Hyuk Moon, Sanjiv S. Gambhir, Erik S. Mittra, Ludger M. Dinkelborg, Christoph A. Schatz, Christina Hultsch, Norman Koglin, Lüder Fels, Claudia Bacher-Stier, Seung Jun Oh, Jin-Sook Ryu, Gyungyub Gong, Jong Won Lee, Sei Hyun Ahn, Chang-Min Choi, Sora Baek
Purpose: (4S)-4-(3-[18F]fluoropropyl)-l-glutamate (BAY 94-9392, alias [18F]FSPG) is a new tracer to image xC− transporter activity with positron emission tomography (PET). We aimed to explore the tumor detection rate of [18F]FSPG in patients relati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78c2e0df8b1d663164112aaa27182b42
https://doi.org/10.1158/1078-0432.c.6522446.v1
https://doi.org/10.1158/1078-0432.c.6522446.v1